Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC) and reach across the industry, the Company identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. 

Biotechnology

Sporos Bioventures

Stephen Rubino

Dana Levy

Sharon Shacham

Eric Rowinsky

The Consulting and Advisory Team at Sporos Bioventures provides expert guidance and strategic insights across medical, scientific, and financial domains. Leveraging their specialized knowledge, they advise on the development and deployment of clinical candidates, innovative technologies, and financial strategies to accelerate the creation of breakthrough medicines for cancer and immune diseases.

Consulting and Advisory Team

About

Team members

Other teams at Sporos Bioventures

Leadership Team